2025 marks a historic turning point for China’s innovative drug industry. According to Wind data, as of October 21, the total value of China’s innovative drug licensing-out transactions exceeded the $100 billion mark, reaching $101.24 billion—far surpassing the $51.9 billion recorded for the entire year of 2024. Industry analysts widely believe that driven by the combined forces of medical insurance payment reform, accelerated global expansion, and technological iteration, China’s innovative drugs are entering a golden decade.

Against this industry backdrop, the upgrading of underlying technical equipment has become a key factor restricting the development of innovative drugs. As a renowned process equipment supplier in the global pharmaceutical industry, Puhler Nano provides pharmaceutical companies with full-process technical support from raw material processing to finished product preparation through its leading micro-nano grinding technology and intelligent production line solutions.

▼

Nano-grinding Technology Solves Key Challenges in Innovative Drug R&D

In the R&D of innovative drugs, the water solubility of active ingredients has long been a key factor limiting efficacy. Industry data shows that since 1995, more than 40% of newly discovered active pharmaceutical ingredients (APIs) have exhibited poor or extremely poor water solubility.

Drug nanonization is an effective approach to addressing this industry pain point. By reducing drug particle size, the surface area increases significantly, leading to a substantial improvement in the dissolution rate of active ingredients and faster onset of action. Studies indicate that enhanced drug bioavailability can also reduce the required amount of API, thereby providing patients with products that have fewer side effects and are more reasonably priced.

With its nano-level grinding precision, stable product quality, and GMP-compliant design, Puhler’s intelligent nano-grinding machines have become the strategic choice for many leading pharmaceutical companies looking to enhance drug efficacy and optimize production processes.

Six Core Advantages of Puhler Nano Grinding Equipment in Pharmaceutical Applications

• Ultimate Fineness: Achieves a minimum particle size of ≤20nm, significantly enhancing drug dissolution and absorption efficiency.

• Precise Temperature Control: Full-process temperature regulation ensures drug stability and activity.

• Compliant Design: Fully meets GMP standards to guarantee product quality and purity.

• Easy Cleaning: Modular design greatly reduces the risk of cross-contamination.

• Intelligent Control: Automated operation minimizes human error and improves product consistency.

• Stability & Reliability: Ensures continuous production to meet large-scale manufacturing needs.

In the race to develop innovative drugs, time is of the essence. Puhler’s nano-grinding equipment helps pharmaceutical companies shorten R&D cycles and improve drug bioavailability, securing valuable time for bringing new drugs to market.

Precision Control & Intelligent Production Lines 

Lead New Technological Breakthroughs

Puhler Nano’s one-stop automated grinding line solutions provide customers with digital, standardized, and intelligent turnkey engineering covering automatic feeding, pre-mixing and dispersion, intelligent batching, precision metering, automatic filling, remote control, grinding, and filtration. The lines are also equipped with comprehensive online cleaning and sterilization functions, meeting GMP standards and enabling seamless integration from laboratory research to industrial-scale production for innovative pharmaceutical enterprises.

Advantages of Puhler Nano’s One-stop Automated Grinding Production Line

Increased Production Efficiency: Automated operations significantly reduce batching time and boost overall efficiency, supporting continuous and batch production to meet large-scale manufacturing demands.
Enhanced Quality Stability: The high-precision control of the automatic batching system effectively eliminates human-induced errors, ensuring the uniformity and stability of each batch to meet the stringent quality requirements of pharmaceutical production.
Flexible Formula Management: Rapid switching and adjustment between different product formulations are supported, facilitating the production of various solid dosage forms and enhancing manufacturing flexibility.
Strengthened Compliance: The entire batching process is conducted in a closed environment, effectively preventing contamination and cross-contamination.
Full Traceability: The system automatically records all process data, including material names, batches, weights, operation times, and operator information, forming complete electronic records for easy quality traceability and troubleshooting.
Cost Reduction: Mechanization replaces manual labor, reducing manpower requirements, labor costs, and material waste, thereby optimizing overall costs and enhancing enterprise competitiveness.